Health News Releases

February 08, 2021 09:54

Celltrion’s COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation

Celltrion Group today announced that the Korean Ministry of Food and Drug Safety (MFDS) granted a Conditional Marketing Authorisation (CMA) for the emergency use of Regdanvimab (CT-P59), an anti-COVID

February 03, 2021 18:08

Data at EAHAD 2021 Highlight Value of Takeda’s Leading Hematology Portfolio in Clinical Settings and Commitment to Patient-Focused Advancements

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced that 14 abstracts from the company’s Hematology portfolio and pipeline are being presented as electronic posters a

February 03, 2021 14:30

Medigate Named Healthcare IoT Security Leader in 2021 Best in KLAS: Software & Services Report

Medigate, a healthcare dedicated device security and asset management company, today announced it was selected as the 2021 Best in KLAS for Healthcare IoT Security in the KLAS Software & Services Repo

February 03, 2021 11:15

Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes

DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording artist, a

February 02, 2021 19:10

Vifor Pharma to propose Dr Alexandre LeBeaut as Board member

Regulatory News: Vifor Pharma today announced that the Board of Directors will propose Dr Alexandre LeBeaut for election to the Board at the next Annual General Meeting on 6 May 2021. Jacques Th

February 02, 2021 16:10

Jackson Memorial, Among World’s Largest Hospitals, Deploys Everbridge Software to Streamline COVID-19 Vaccine Distribution, Representing Growing Adoption in the Healthcare Industry

Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced that a growing number of organizations across industry verticals, including healthcare and govern

February 01, 2021 16:45

Takeda Completes Sale of TachoSil® to Corza Health

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has completed the previously announced sale of TachoSil® Fibrin Sealant Patch (“TachoSil®”) to Corza Health

February 01, 2021 14:30

Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera S

January 29, 2021 14:00

Thousand Oaks Biopharmaceuticals Inked a Joint Venture Agreement with Korea’s WSG Group

January 2021, Thousand Oaks Biopharmaceuticals Group (“Thousand Oaks”) announced that it had signed a Joint Venture agreement with WSG Group in Busan, Korea, to establish a bioprocess solution joint v

January 29, 2021 13:10

Takeda Presents Positive Results For Mobocertinib in Patients with EGFR Exon20 insertion+ mNSCLC Who Received Prior Platinum-based Chemotherapy

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from the Phase 1/2 trial of mobocertinib (TAK-788) orally administered in previously treated patients with

January 28, 2021 13:50

Takeda Achieved Carbon Neutrality in 2020

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it achieved carbon neutrality in its value chain for its fiscal year 2019. This achievement was delivered by a

January 27, 2021 13:20

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company ac

January 27, 2021 11:35

New Study Concludes Xlear Kills and/or Deactivates SARS-CoV-2; Efficacy Against New Variants

A new in vitro study done collaboratively by Utah State University and Northwestern University finds Xlear components (grapefruit seed extract and xylitol) significantly eliminates SARS-CoV-2, the vir

January 27, 2021 10:58

Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis

Mundipharma and Cidara Therapeutics today announced that the European Commission (EC) has now adopted the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP) recommendatio

January 26, 2021 14:30

Everbridge Awarded Statewide Vaccine Distribution Deployment Across West Virginia; Everbridge Software Enables Governments, Hospitals and Businesses to Coordinate Rapid Delivery and Communications of COVID-19 Vaccine

Everbridge, Inc. (NASDAQ: EVBG), the global leader in critical event management (CEM), today announced COVID-19 Shield™: Vaccine Distribution, an extension to its CEM platform offering risk insights,

January 25, 2021 14:20

Takeda Named Global Top Employer for Fourth Consecutive Year

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receivin

January 22, 2021 10:57

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Admin

January 20, 2021 16:45

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 With Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation System™ and Solid Targets

ARTMS Inc. (ARTMS) and Isotopia Molecular Imaging (Isotopia) are pleased to announce the successful radiolabeling of Isotopia’s prostate cancer imaging kit product, PSMA-11, with over 2 Ci of cyclotro

January 19, 2021 17:40

Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma

FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY The Mundipharma network of independently associated companies today announced two new appointments to their Executive Committee - Julie Dehaene-Puype

January 19, 2021 13:31

Asia Invests in Biotechnology Innovations to Boost Food Safety, Sustainability

Asia is actively investing in biotechnology innovations to meet the needs of its rapidly growing population. Calysseo’s FeedKind® single-cell protein project is one such biotechnology innovation th

January 14, 2021 11:50

Takeda Provides Pipeline Update and Shares Goal to Increase Revenue 50% by FY2030 at the 39th Annual J.P. Morgan Healthcare Conference

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) provided an update on the progress of its continued transformation and growth today at the virtual 39th Annual J.P. Morgan Healthca

January 14, 2021 11:08

Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59

Celltrion Group today announced top-line results from its randomised, double-blind, and placebo controlled global Phase II/III clinical trial of CT-P59, an anti-COVID-19 monoclonal antibody treatment

January 13, 2021 16:55

Dr. Mike Durkin Assumes Role as Vice Chairman of Patient Safety Movement Foundation Board of Directors

The Patient Safety Movement Foundation (PSMF), a global non-profit on a mission to achieve zero preventable patient deaths by 2030, has appointed Mike Durkin, OBE, MBBS, FRCA, FRCP, DSc to serve as vi

January 13, 2021 16:10

ARTMS and Telix Pharmaceuticals Announce Successful Production of PSMA-11 with Cyclotron Produced 68Ga from a Solid Target

ARTMS Inc. (‘ARTMS’) and Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’) are pleased to announce they have successfully produced Telix’s prostate cancer imaging product, TLX591-CDx (Kit for the prep

January 13, 2021 09:40

Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies

Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic collaboration and licensing agreement to research and develop novel targeted cancer immunotherapies, leverag

News by Region

News by Industry